Emicizumab prophylaxis and health-related outcomes in persons with hemophilia a (PwHA) with inhibitors: HAVEN 1 study

被引：0
|
作者：
Oldenburg, J. [1 ]
Mahlangu, J. N. [2 ,3 ]
Bujan, W. [4 ]
Trask, P. C. [5 ]
von Mackensen, S. [6 ]
Callaghan, M. U. [7 ]
Young, G. [8 ]
Asikanius, E. [9 ]
Peyvandi, F. [10 ]
Santagostino, E. [10 ]
Kruse-Jarres, R. [11 ]
Negrier, C. [12 ]
Kessler, C. [13 ]
Levy, G. G. [14 ]
Windyga, J. [15 ]
Shima, M. [16 ]
机构：
[1] Univ Klinikum Bonn, Bonn, Germany
[2] Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, Johannesburg, South Africa
[3] NHLS, Johannesburg, South Africa
[4] Inst Costarricense Invest Cient, San Jose, Costa Rica
[5] Genentech Inc, San Francisco, CA 94080 USA
[6] Univ Med Ctr Hambur Eppendorf, Dept Med Psychol, Hamburg, Germany
[7] Childrens Hosp Michigan, Detroit Med Ctr, Detroit, MI 48201 USA
[8] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA USA
[9] F Hoffmann La Roche Ltd, Basel, Switzerland
[10] Osped Maggiore Policlin, IRCCS Ca Granda Fdn, Milan, Italy
[11] Univ Washington, Washington Ctr Bleeding Disorders BloodWorks NW, Seattle, WA 98195 USA
[12] Univ Claude Bernard, Louis Pradel Cardiol Hosp, Lyon, France
[13] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[14] Genentech Inc, Pharma Dev Oncol, San Francisco, CA 94080 USA
[15] Inst Hematol & Transfus Med, Warsaw, Poland
[16] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P120
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] Emicizumab prophylaxis in paediatric persons with haemophilia A (PWHA) with inhibitors: Impact on health-related outcomes and caregiver burden in the HAVEN 2 study
    Mancuso, M. E.
    Mahlangu, J.
    Sidonio, R. F., Jr.
    Trask, P. C.
    von Mackensen, S.
    Shima, M.
    Uguen, M.
    Chang, T.
    Young, G.
    Oldenburg, J.
    [J]. HAEMOPHILIA, 2018, 24 : 28 - 29
  • [2] The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study
    Oldenburg, Johannes
    Mahlangu, Johnny N.
    Bujan, Willem
    Trask, Peter
    Callaghan, Michael U.
    Young, Guy
    Asikanius, Elina
    Peyvandi, Flora
    Santagostino, Elena
    Kruse-Jarres, Rebecca
    Negrier, Claude
    Kessler, Craig
    Xu, Jin
    Windyga, Jerzy
    Shima, Midori
    von Mackensen, Sylvia
    [J]. HAEMOPHILIA, 2019, 25 (01) : 33 - 44
  • [3] Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3
    Kiialainen, Anna
    Niggli, Markus
    Kempton, Christine L.
    Castaman, Giancarlo
    Chang, Tiffany Y.
    Paz-Priel, Ido
    Adamkewicz, Joanne I.
    Levy, Gallia G.
    [J]. BLOOD, 2019, 134
  • [4] Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
    Schmitt, Christophe
    Adamkewicz, Joanne I.
    Xu, Jin
    Petry, Claire
    Catalani, Olivier
    Young, Guy
    Negrier, Claude
    Callaghan, Michael U.
    Levy, Gallia G.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 351 - 360
  • [5] Bone and joint health markers in persons with haemophilia A (PwHA) treated with emicizumab in HAVEN 3
    Kiialainen, A.
    Niggli, M.
    Kempton, C.
    Castaman, G.
    Chang, T.
    Paz-Priel, I.
    Adamkewicz, J.
    Levy, G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 151 - 152
  • [6] Surgical procedures in persons with haemophilia A (PWHA) without inhibitors receiving emicizumab - Experience from the HAVEN 3 study
    Santagostino, E.
    Parnes, A.
    Dhalluin, C.
    Oldenburg, J.
    Niggli, M.
    Lambert, T.
    Kempton, C.
    Ko, R. H.
    Han, J. W.
    Wozny, T.
    Paz-Priel, I.
    Levy, G. G.
    Mahlangu, J.
    [J]. HAEMOPHILIA, 2019, 25 : 33 - 33
  • [7] Health-related quality of life in children with severe hemophilia A on emicizumab prophylaxis
    Hassan, Ahmed S.
    Sherief, Laila M.
    Hamdy, Mona
    Abbas, Ahmed M.
    Elagamy, Osama
    [J]. EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (02): : 192 - 196
  • [8] Immunogenicity of Emicizumab in People with Hemophilia A (PwHA): Results from the HAVEN 1-4 Studies
    Paz-Priel, Ido
    Chang, Tiffany
    Asikanius, Elina
    Chebon, Sammy
    Emrich, Thomas
    Fernandez, Elena
    Kuebler, Peter
    Schmitt, Christophe
    [J]. BLOOD, 2018, 132
  • [9] Health-related outcomes and caregiver burden in pediatric persons with hemophilia A (PwHA) with inhibitors: prospective, non-interventional study (NIS) in a real-world setting
    Jimenez-Yuste, Victor
    Trask, Peter
    Chebon, Sammy
    Mahlangu, Johnny
    Oldenburg, Johannes
    Lehle, Michaela
    Shima, Midori
    von Mackensen, Sylvia
    Mancuso, Maria
    [J]. HAEMOPHILIA, 2018, 24 : 181 - 181
  • [10] Timing of treated spontaneous bleeding in persons with haemophilia A (PwHA) with inhibitors in the HAVEN 1 study
    Kruse-Jarres, R.
    Trzaskoma, B.
    Raimundo, K.
    Tzeng, E.
    Sanz, B. Perez
    Ko, R. H.
    [J]. HAEMOPHILIA, 2019, 25 : 160 - 161
12345